The prevalence of obstructive sleep apnea (OSA)

Similar documents
Methods of Diagnosing Sleep Apnea. The Diagnosis of Sleep Apnea: Questionnaires and Home Studies

Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea

Predictive value of clinical features for the obstructive sleep apnoea syndrome

Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea

The Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS)

Inspiratory flow-volume curve in snoring patients with and without obstructive sleep apnea

Prediction of sleep-disordered breathing by unattended overnight oximetry

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

Obstructive sleep apnoea How to identify?

DECLARATION OF CONFLICT OF INTEREST

ORIGINAL ARTICLES. Adaptation to Nocturnal Intermittent Hypoxia in Sleep-Disordered Breathing: 2,3 Diphosphoglycerate Levels: A Preliminary Study

Polysomnography (PSG) (Sleep Studies), Sleep Center

Internet Journal of Medical Update

Step (2) Looked for correlations between baseline surrogates and postoperative AHI.

The STOP-Bang Equivalent Model and Prediction of Severity

Nasal pressure recording in the diagnosis of sleep apnoea hypopnoea syndrome

PREDICTIVE VALUE OF AUTOMATED OXYGEN SATURATION ANALYSIS FOR THE DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN A HOME-BASED SETTING

More than 20 years ago, before obstructive sleep. Gender Differences in Sleep Apnea* The Role of Neck Circumference

O bstructive sleep apnoea-hypopnoea (OSAH) is a highly

(To be filled by the treating physician)

Effect of body mass index on overnight oximetry for the diagnosis of sleep apnea

Frequency-domain Index of Oxyhemoglobin Saturation from Pulse Oximetry for Obstructive Sleep Apnea Syndrome

A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation

Obstructive sleep apnea (OSA) is characterized by. Quality of Life in Patients with Obstructive Sleep Apnea*

Predictive Value of Clinical Features in Diagnosing Obstructive Sleep Apnea

F. Barbé*, M.A. Quera-Salva**, C. McCann**, Ph. Gajdos**, J.C. Raphael**, J. de Lattre**, A.G.N. Agustí*

Pharyngeal Critical Pressure in Patients with Obstructive Sleep Apnea Syndrome Clinical Implications

Sleep Apnea: Vascular and Metabolic Complications

Monitoring: gas exchange, poly(somno)graphy or device in-built software?

Evaluation of the Brussells Questionnaire as a screening tool

Interrelationships between Body Mass, Oxygen Desaturation, and Apnea-Hypopnea Indices in a Sleep Clinic Population

Sleep Apnea: Diagnosis & Treatment

An update on childhood sleep-disordered breathing

CPAP titration by an auto-cpap device based on snoring detection: a clinical trial and economic considerations

Simple diagnostic tools for the Screening of Sleep Apnea in subjects with high risk of cardiovascular disease

Policy Specific Section: October 1, 2010 January 21, 2013

Increasing the Functional Residual Capacity May Reverse Obstructive Sleep Apnea

In 1994, the American Sleep Disorders Association

Triennial Pulmonary Workshop 2012

Basics of Polysomnography. Chitra Lal, MD, FCCP, FAASM Assistant professor of Medicine, Pulmonary, Critical Care and Sleep, MUSC, Charleston, SC

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

José Haba-Rubio, MD; Jean-Paul Janssens, MD; Thierry Rochat, MD, PhD; and Emilia Sforza, MD, PhD

The use of overnight pulse oximetry for obstructive sleep apnoea in a resource poor setting in Sri Lanka

Efremidis George, Varela Katerina, Spyropoulou Maria, Beroukas Lambros, Nikoloutsou Konstantina, and Georgopoulos Dimitrios

Patients with COPD run a risk of developing. Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD*

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Is CPAP helpful in severe Asthma?

Overnight fluid shifts in subjects with and without obstructive sleep apnea

OSA and COPD: What happens when the two OVERLAP?

PEDIATRIC SLEEP GUIDELINES Version 1.0; Effective

Overlap Syndrome. José M. Marin Hospital Universitario Miguel Servet Zaragoza, Spain.

Assessment of a wrist-worn device in the detection of obstructive sleep apnea

Zia H Shah MD FCCP. Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction

Average volume-assured pressure support

Diabetes & Obstructive Sleep Apnoea risk. Jaynie Pateraki MSc RGN

BTS sleep Course. Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith)

Albert L. Rafanan, MD; Joseph A. Golish, MD, FCCP; Dudley S. Dinner, MD; L. Kathleen Hague, RN; and Alejandro C. Arroliga, MD, FCCP

Key words: bed partners; polysomnography; questionnaires; rhinomanometry; sleep apnea

The effects of sleep-disordered breathing (SDB)

Risk factors associated with habitual snoring and sleep-disordered breathing in a multi-ethnic Asian population: a population-based study

International Journal of Scientific & Engineering Research Volume 9, Issue 1, January ISSN

Medicare CPAP/BIPAP Coverage Criteria

2/13/2018 OBESITY HYPOVENTILATION SYNDROME

Clinical pulmonary physiology. How to report lung function tests

The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea*

The most common functional impairment in patients. Predictors of Oxygen Desaturation During Submaximal Exercise in 8,000 Patients*

In-Patient Sleep Testing/Management Boaz Markewitz, MD

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016

Portable Computerized Polysomnography in Attended and Unattended Settings*

Key words: hypoxemia; obesity; obstructive sleep apnea-hypopnea syndrome; subcutaneous fat accumulation; visceral fat accumulation

Obesity, Weight Loss and Obstructive Sleep Apnea

PFT Interpretation and Reference Values

GOALS. Obstructive Sleep Apnea and Cardiovascular Disease (OVERVIEW) FINANCIAL DISCLOSURE 2/1/2017

Accuracy of Oximetry for Detection of Respiratory Disturbances in Sleep Apnea Syndrome*

Evaluation of a 2-Channel Portable Device and a Predictive Model to Screen for Obstructive Sleep Apnea in a Laboratory Environment

The Effect of Patient Neighbourhood Income Level on the Purchase of Continuous Positive Airway

Epidemiology and diagnosis of sleep apnea

Christopher D. Turnbull 1,2, Daniel J. Bratton 3, Sonya E. Craig 1, Malcolm Kohler 3, John R. Stradling 1,2. Original Article

1/27/2017 RECOGNITION AND MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA: STRATEGIES TO PREVENT POST-OPERATIVE RESPIRATORY FAILURE DEFINITION PATHOPHYSIOLOGY

Oxygen treatment of sleep hypoxaemia in Duchenne

Update on Sleep Apnea Diagnosis and Treatment

PHYSICIAN EVALUATION AMONG DENTAL PATIENTS WHO SCREEN HIGH-RISK FOR SLEEP APNEA. Kristin D. Dillow

Does AHI Value Enough for Evaluating the Obstructive Sleep Apnea Severity?

Proposed Decision Memo for Sleep Testing for Obstructive Sleep Apnea (OSA) (CAGimage 00405N)

Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients

Hypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment

The recommended method for diagnosing sleep

Coding for Sleep Disorders Jennifer Rose V. Molano, MD

Berlin Questionnaire and Portable Monitoring Device for Diagnosing Obstructive Sleep Apnea: A Preliminary Study in Jakarta, Indonesia

Opioids Cause Central and Complex Sleep Apnea in Humans and Reversal With Discontinuation: A Plea for Detoxification

High Flow Nasal Cannula in Children During Sleep. Brian McGinley M.D. Associate Professor of Pediatrics University of Utah

PORTABLE OR HOME SLEEP STUDIES FOR ADULT PATIENTS:

Mandibular Advancement Device : Long-term Effects on Apnea and Sleep

Obstructive sleep apnea has long been observed. A Community Study of Sleep- Disordered Breathing in Middle-Aged Chinese Women in Hong Kong*

Acceptance and long-term compliance with ncpap in patients with obstructive sleep apnoea syndrome

Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

Sleep Studies: Attended Polysomnography and Portable Polysomnography Tests, Multiple Sleep Latency Testing and Maintenance of Wakefulness Testing

Transcription:

Value of Clinical, Functional, and Oximetric Data for the Prediction of Obstructive Sleep Apnea in Obese Patients* Bertrand Herer, MD; Nicolas Roche, MD; Matthieu Carton, MD; Catherine Roig, MD; Vincent Poujol, MD; and Gérard Huchon, MD, FCCP Objective: To evaluate the diagnostic value of clinical features, pulmonary function testing, blood gas tensions, and oximetric data for case finding of obstructive sleep apnea (OSA) before polysomnography (PSG) in a series of consecutive overweight patients. Methods: We studied a population of 102 consecutive patients referred by an obesity clinic for suspected OSA, in whom body mass index was > 25 kg/m 2. The following tests were performed: clinical score (CS), pulmonary function tests (PFTs), measurement of arterial blood gas tensions, nocturnal oximetry, and full-night PSG. Results: Six of 34 women and 34 of 68 men had OSA, defined by an apnea-hypopnea index > 15. CS and the cumulative time spent below 80% arterial oxygen saturation (SaO 2 ) were higher, and PaO 2, minimal SaO 2, and mean nocturnal SaO 2 (msao 2 ) were lower in OSA patients than in non-osa patients. Logistic regression showed that sex, CS, and the ratio of FEV 1 over forced expiratory volume in 0.5 s (an index of upper airway obstruction on flow-volume curves) and msao 2, expressed as categorical variables, were independent predictors of OSA. None of these individual variables had a satisfactory diagnostic value for the diagnosis of OSA. A logistic regression model including sex and all continuous variables would have allowed us to predict the presence or absence of OSA confidently in 72.5% of the population, in whom the positive predictive value of the model was 94% and the negative predictive value was 90%. Conclusion: In obese patients referred to a respiratory sleep laboratory and evaluated by CS, PFTs, arterial blood gases, and oximetry, no individual sign or symptom may accurately predict the presence or absence of OSA. Provided that it is validated in prospective studies, a logistic regression model using these variables may be useful for the prediction of OSA. (CHEST 1999; 116:1537 1544) Key words: clinical score; obesity; obstructive sleep apnea; oximetry; polysomnography; upper airway obstruction Abbreviations: AHI apnea-hypopnea index; BMI body mass index; CS clinical score; CT 80 cumulative time spent with arterial oxygen saturation below 80%; CT 90 cumulative time spent with arterial oxygen saturation below 90%; FEF 50 /FIF 50 ratio of the forced expiratory flow after 50% of the FVC over the forced inspiratory flow after 50% of the FVC; FEV 1 /FEV 0.5 ratio of FEV 1 over forced expiratory volume in 0.5 s; minsao 2 minimal nocturnal arterial oxygen saturation; msao 2 mean nocturnal arterial oxygen saturation; NS not significant; OSA obstructive sleep apnea; P probability of having obstructive sleep apnea; PEF/FEF 50 ratio of peak expiratory flow over forced expiratory flow after 50% of the FVC; PFT pulmonary function test; PSG polysomnography; ROC receiver operating characteristics; Sao 2 arterial oxygen saturation; UAO upper airway obstruction *From Centre Médical de Forcilles (Drs. Herer, Roig, and Poujol), Férolles-Attilly, France; and Service de Pneumologie (Drs. Roche and Huchon) and Département d Informatique Médicale et de Biostatistiques (Dr. Carton), Université de Paris René Descartes, Hôpital Ambroise-Paré, Boulogne, France. Manuscript received February 3, 1999; revision accepted July 6, 1999. Correspondence to: Gérard J. Huchon, MD, FCCP, Service de Pneumologie et Réanimation, Hôpital de l Hôtel-Dieu 1 Place du Parvis de Notre Dame, F-75181 Paris Cedex 4, France; e-mail: gerard.huchon@htd.ap-hop-paris.fr The prevalence of obstructive sleep apnea (OSA) has recently been reported to be 2% in women and 4% in men. 1 Obesity and male sex are strongly associated with the presence of sleep disordered breathing. 1,2 The male predominance may be the result of greater self-selection and referral bias, but may also reflect sex differences in endogenous (eg, upper airway anatomy) or exogenous (eg, alcoholic intoxication) etiologic agents. 3,4 Despite recent debates on which measurements CHEST / 116 / 6/ DECEMBER, 1999 1537

best describe OSA, the gold standard for the diagnosis of this disease remains polysomnography (PSG), which is expensive and time-consuming. Therefore, investigations have been proposed for appropriate case finding before PSG is performed in patients referred for sleep evaluation, in order to limit the number of PSG tests done. 5 10 However, predictive factors and their diagnostic values are likely to differ according to the characteristics of the population studied (eg, sex, obesity, underlying respiratory diseases), making it inappropriate to extrapolate results from a given population to patients referred to another laboratory, and making it necessary to determine the best predictive factors for various populations. 9 Besides, most studies on predictors of OSA have not included the results of pulmonary function tests (PFTs) and blood gas measures in the analysis. 5 10 Because obesity is a strong risk factor for OSA, 2 practitioners who care for obese patients must frequently suspect the presence of OSA. Therefore, we studied the predictive values of clinical evaluation, PFTs, arterial blood gas tensions, and nocturnal oximetry for OSA case finding in a population of consecutive overweight patients. Because female patients represent approximately one third of patients referred to our laboratory quite a high proportion compared with that reported in other studies we also assessed the effect of sex on these predictive values. Study Population Materials and Methods We analyzed the data from 102 consecutive new overweight patients referred to the respiratory sleep laboratory by the obesity clinic between May 1992 and November 1994. All patients had a body mass index (BMI), calculated as (weight [kg])/(height [m]) 2, of 25 kg/m 2. In each patient, a clinical score (CS) was established and PFTs, nocturnal oximetry, and full-night PSG were performed. Clinical Score We used a CS derived from Williams et al, 10 including four features: habitual snoring, interrupted nocturnal breathing as reported by the spouse or roommates, excessive daytime sleepiness, and arterial hypertension. Each feature was assigned a score of 0 or 1, with a highest possible value of 4 for the whole score. BMI was not included in the score because it was 25 kg/m 2 in all patients. Pulmonary Function Testing PFTs included spirometry and flow-volume curve analysis (Medical Graphics Corp; St. Paul, MN). The predicted values of the European Community for Coal and Steel were used for PFTs. 11 Flow-volume curves were examined for the presence of saw-toothing, 12 and the following flow ratios used for the diagnosis of upper airway obstruction (UAO) 13 15 were calculated: the ratio of the forced expiratory flow after 50% of the FVC over the forced inspiratory flow after 50% of the FVC (FEF 50 / FIF 50 ), the ratio of peak expiratory flow over FEF 50 (PEF/ FEF 50 ), and the ratio of FEV 1 over forced expiratory volume in 0.5 s (FEV 1 /FEV 0.5 ). Arterial blood samples were obtained by radial artery puncture while the patient was seated. Oximetry Pulse oximetry was performed overnight 1 to 7 days prior to PSG. The recording was done in the sleep laboratory with portable systems, ie, either a Biox 3740 (Ohmeda; Louisville, CO), a Pulsox-8 (Minolta, AVL Medical Instruments; Cergy- Pontoise, France), or an OLV-1100 (Nihon-Kohden; Tokyo, Japan) oximeter. Stored data were digitized for computer analysis, and the following indices were calculated: minimal nocturnal arterial oxygen saturation (minsao 2 ), mean nocturnal Sao 2 (msao 2 ), and cumulative time spent with an Sao 2 below 90% (CT 90 ) and below 80% (CT 80 ). Oximetry was not performed during the same night as PSG. PSG All patients underwent a full-night PSG including two channels of EEG, one channel of electro-oculogram, and one channel of submental electromyogram. Thoracoabdominal movements were recorded with inductance plethysmography. Airflow at the nose and mouth was assessed by a thermistor. All signals were recorded and stored on semiautomated scoring systems (Minisomno; SEFAM; Nancy, France; or Medatec; Brussels, Belgium). Apnea was defined as cessation of oronasal airflow for 10 s. Obstructive apneas were scored when airflow was absent but respiratory efforts were present. Hypopnea was defined as a reduction of oronasal airflow to 50% of the value prevailing during a preceding period of normal breathing of 10 s. OSA was defined as a combined obstructive apnea-hypopnea index (AHI) of 15 events/h. 16,17 Statistical Analysis We used Student s t tests to study differences in CS, pulmonary function variables, arterial blood gases, and results of nocturnal pulse oximetry between patients with OSA (AHI 15/h) and patients without OSA (AHI 15/h). We assessed the correlations between these variables and AHI using the nonparametric Spearman rank test because AHI was not normally distributed according to the Shapiro-Wilks test. Then, we used receiver operating characteristics (ROC) curves to determine the most accurate diagnostic thresholds for variables that correlated to AHI or differed in OSA and non-osa patients. The obtained thresholds were used to transform the continuous variables into categorical variables, and Pearson s 2 test was performed to study differences in distribution of these categorical variables between OSA and non-osa patients. Multivariate logistic regression analysis was used to determine which categorical variables were independently predictive of OSA and to study the interaction between predictive variables and sex. Logistic regression analysis was also used to develop a model for prediction of OSA. The probability of having OSA (P) was calculated using the following equation: p e y /(1 e y ), where y c (constant) x 1 Variable1 x 2 Variable2 x 3 Vari- 1538 Clinical Investigations

able3, etc. The constant (c) and parameter estimates (x 1,x 2,x 3, etc) were determined by a logistic regression analysis in which presence or absence of OSA was the dependent variable, and in which sex and all continuous variables were first introduced. 9 The step-by-step Wald method was then used to restrict variables introduced in the equation to those that independently correlated to the presence of OSA. Goodness of fit of the logistic models was assessed using Hosmer and Lemeshow test. The correlation between P and AHI was studied by the Spearman rank test, and the positive and negative predictive values of various thresholds of P were calculated by ROC curve analysis. Finally, individual data were analyzed to determine if some ranges or combinations of ranges of variables were highly predictive of either the presence or the absence of OSA. Results are expressed as mean SD unless indicated. We considered a p value 0.05 to be significant. Logistic regression analysis was repeated with an AHI threshold of 10 for definition of OSA. Statistical analysis was performed with BMDP (BMDP Statistical Software; Los Angeles, CA), SPSS (SPSS Inc; Chicago, IL) and SAS (SAS Institute; Cary, NC) statistical software. ROC curve analysis was performed with ROC Analyzer software (RM Centor and J Keightley; Richmond, VA). Results The study population consisted of 34 women and 68 men, whose characteristics are summarized in Table 1. BMI and FEV 1 /FVC were higher and tobacco smoking was less frequent in women than in men. OSA was more frequent in men (p 0.01; Table 1). Airflow obstruction (as defined by the American Thoracic Society 18 ) was present in 28% of our male population vs 12% of women, but this difference did not reach significance (p 0.08). The proportion of patients with OSA did not differ between subjects with or without airflow obstruction, among both men and women (data not shown; p not significant [NS] for all comparisons). AHI did not correlate with FEV 1 and FEV 1 /FVC (r 0 0.402 and r 0.265, respectively; p NS). Patients with OSA exhibited the following characteristics when compared with those who did not have OSA: higher CS, lower diurnal Pao 2, lower nocturnal minsao 2, msao 2, and higher CT 80 (Table 2). These differences were found for continuous as well as for categorical variables. Thresholds used for transformation of continuous variables into categorical variables, as determined by ROC curve analysis, are shown in Table 3. Table 3 also shows the sensitivity and specificity of these individual variables for the diagnosis of OSA. Multivariate logistic regression analysis showed that sex, CS, FEV 1 /FEV 0.5, and msao 2 were independent predictors of OSA when computed as categorical variables (Table 4). There was no interaction between sex and other predictive variables. The relationships between AHI and these predictive variables are shown in Figures 1, 2. The parameter estimates calculated by logistic regression when all variables were used in the analysis are shown in Table 5 and were used to calculate P, as described in the methods section. The calculated probability of having OSA (P) correlated to AHI (Spearman s, r 0.66; p 10 11 ), and a value of P 0.75 (n 21, 20.5% of patients) had a positive predictive value of 90% for the diagnosis of OSA, whereas a value of P 0.35 (n 53, 52.0% of patients) had a negative predictive value of 94% for the diagnosis of absence of OSA (Fig 3, left). Restricting the variables used to those that independently correlated to the presence of OSA, the step-by-step Wald method yielded the following equation: y 4.31 (1.41 sex) (0.03 CT 80 ) (0.78 CS) where y is used to calculate P as described above. P correlated to AHI less strongly than P (r 0.29; p 0.01); the only useful feature that could be derived from the plot of P against AHI was that a value of P 0.25 (n 13, 12.7% of patients) had a negative predictive value of 80% for exclusion of OSA (Fig 3, right). Results of multivariate analysis were not altered by using a different AHI threshold to define OSA, ie, 10 or 15 events/h (Table 4). Table 1 Anthropometric, Polysomnographic, and Pulmonary Function Data* Women Men No OSA OSA No OSA OSA No. of patients 28 6 34 34 Age, yr 53.5 10.9 53.0 17.8 51.7 10.7 54.4 10.1 BMI, kg/m 2 43.4 9.4 53.5 13.3 36.3 6.5 37.2 7.9* Tobacco smoking, No. (pack-yr) 8 (12 24) 1 (10) 27 (32 29) 28 (31 29)* AHI, events/h 3.6 4.1 45.8 19.3 4.5 3.8 42.2 19.0 FVC, % pred 81.2 19.1 91.0 18.4 83.0 18.5 82.4 17.8 FEV 1, % pred 83.9 19.7 87.8 14.1 76.7 24.6 80.6 21.4 FEV 1 /FVC, % pred 85.1 9.1 82.2 10.7 73.9 13.7 77.9 9.5* *Data expressed as mean SD; p 0.05 for the comparison between men and women. CHEST / 116 / 6/ DECEMBER, 1999 1539

Table 2 CS, Arterial Blood Gases, Indices of UAO, and Oximetric Data* No OSA OSA p Value No. of patients 62 40 CS 2.6 1.0 3.3 0.8 0.05 Pao 2, mm Hg 76.7 16.1 70.9 11.7 0.05 Paco 2, mm Hg 41.3 5.7 42.8 5.01 NS Aa gradient, mm Hg 21.8 13.9 25.6 8.6 NS UAO criteria Saw-toothing, % 45 58 NS FEF 50 /FIF 50 1.2 0.6 1.3 0.6 NS FEV 1 /FEV 0.5 1.3 0.2 1.3 0.1 NS PEF/FEF 50 2.3 1.7 2.1 1.0 NS Oximetry, % minsao 2 66.5 12.7 58.5 15.7 0.05 msao 2 87.9 4.5 82.9 10.2 0.05 CT 90 55.4 35.4 61.7 31.8 NS CT 80 9.4 17.2 23.9 25.7 0.05 *Data expressed as mean SD. Aa gradient alveolo-arterial oxygen gradient. Finally, individual data analysis found that all patients who had a CS of 4, FEV 1 /FEV 0.5 ratio 1.3, and msao 2 85% (ie, 3% of the population) had OSA confirmed by PSG, whereas all patients who had a CS of 2, FEV 1 /FEV 0.5 ratio 1.3, and msao 2 85% (ie, 5% of the population) had the diagnosis of OSA eliminated by PSG. We were unable to define any other ranges or combinations of ranges of variables with intermediate as opposed to low predictive value. Discussion Our data show that in an overweight population, CS, PFTs, and nocturnal oximetry taken alone may not accurately predict the presence or absence of Table 3 Best Thresholds and Diagnostic Characteristics of Clinical, Oximetric, and Functional Variables Threshold Sensitivity Specificity Area Under ROC Curve (Mean SEM) msao 2 85% 0.48 0.80 0.67 0.05 CT 80 5% 0.63 0.66 0.67 0.05 CS 3 0.80 0.45 0.64 0.05 Pao 2, mm Hg 70 0.53 0.64 0.64 0.05 FEV 1 /FEV 0.5 1.3 0.65 0.56 0.62 0.06 FEV 1 80% 0.65 0.53 0.59 0.06 FEF 50 /FIF 50 120 0.58 0.59 0.59 0.06 PEF/FEF 50 175 0.59 0.53 0.54 0.06 OSA. As shown in Figures 1, 2, there is a considerable overlap between patients with and without OSA, even for variables that independently predict OSA according to logistic regression, and even when ROC curve analysis is used to determine the best thresholds for each of these variables. In 72.5% of the population, a complex logistic regression model would predict the presence or absence of OSA with a positive predictive value of 94% and a negative predictive value of 90%. As in most studies, patients referred to the sleep laboratory for suspected OSA were predominantly middle-aged, obese men. However, the proportion of obese patients and their mean BMI were higher than in other studies, 9,19,20 which is likely due to the fact that several units in our facility are devoted to the management of obesity. Women represented one third of the population; however the male-tofemale ratio was approximately 6:1 for patients with OSA, which is similar to values reported in other clinic-based samples (ie, 6:1 to 7:1), 4,7 but higher than the ones reported in community-based samples (ie, 2:1 to 3:1). 1,21 Table 4 Results of Multivariate Analysis: Independent Predictors of OSA, as Defined by an AHI of > 10 or > 15 Events/h* Risk of AHI 10/h Risk of AHI 15/h Variables AOR 95% CI p Value AOR 95% CI p Value Sex Female 1 1 Male 5.4 1.7 17.2 0.01 5.7 1.7 19.6 0.01 CS 2 1 1 3 2.8 0.9 9.2 0.09 2.2 0.6 7.9 NS 4 3.5 1.0 12.2 0.05 3.8 1.0 13.6 0.04 FEV 1 /FEV 0.5 1.3 1 1 1.3 3.9 1.3 11.9 0.01 3.1 1.0 9.3 0.04 msao 2, per 5% decrease 1.8 1.1 2.9 0.02 1.9 1.2 3.2 0.05 *AOR adjusted odds ratio; CI confidence interval. Wald s test; goodness of fit of the model (Hosmer and Lemeshow test): p 0.38. 1540 Clinical Investigations

Figure 1. AHI as a function of CS (left) and sex (right), which were both independent predictors of OSA according to logistic regression. Horizontal lines indicate the polysomnographic threshold for the diagnosis of OSA (AHI 15 events/h). In the left panel, the vertical line indicates the best threshold of clinical score for prediction of OSA, as determined by ROC curve analysis. To study the clinical features of patients with suspected OSA, we used a CS derived from Williams et al, 10 who showed that BMI, hypertension, snoring, and gasping or choking observed by a partner were significant predictors of sleep apnea severity. BMI had to be excluded in the score we used because all our patients were overweight (BMI 25 kg/m 2 ). Other authors have developed similar scores based on neck circumference instead of BMI, 7,22 but the predictive value of this index has been questioned. 9 The relationships between OSA, abnormalities Figure 2. AHI as a function of FEF 50 /FIF 50 (left) and msao 2 (right), which were both independent predictors of OSA according to logistic regression. Horizontal lines indicate the polysomnographic threshold for the diagnosis of OSA (AHI 15 events/h). Vertical lines indicate the best thresholds of these variables for prediction of OSA, as determined by ROC curve analysis. CHEST / 116 / 6/ DECEMBER, 1999 1541

Table 5 Parameter Estimates Used to Assess the Probability of Having OSA (As Defined by an AHI of > 15 Events/h), as Calculated by Logistic Regression Analysis When All Variables Were Introduced* Variable Parameter Estimate p Value Clinical features Age 1.17 0.01 Sex 5.22 0.01 BMI 0.12 0.05 CS 0.78 0.05 Arterial blood gases Pao 2 0.08 NS Paco 2 0.02 NS Usual expiratory flow-volume curve variables FVC 0.40 NS FEV 1 0.41 NS FEV 1 /FVC 0.17 NS FEF 25 75 0.01 NS UAO criteria FEV 1 /FEV 0.5 0.14 NS PIF 0.27 NS FEF 50 /FIF 50 0.01 NS PEF/FEF 50 0.04 0.01 FEV 1 /PEF 2.09 0.01 Nocturnal oximetry msao 2 1.65 0.05 minsao 2 0.08 NS CT 80 0.15 NS CT 90 0.15 0.01 Constant 148.47 0.05 *PIF peak inspiratory flow; FEF 25 75 forced expiratory flow between 25 and 75% of the forced vital capacity. of resting diurnal gas exchanges, and pulmonary function are controversial. We observed a lower diurnal Pao 2 in patients with OSA than in patients without OSA. Because only a small proportion of OSA patients had an associated bronchial obstruction (6/40, 15%), this resting hypoxemia may be in part explained by high BMI. Indeed, several studies conducted in predominantly obese populations found values of Pao 2 similar to those of our patients. 23 25 Among them, Gold et al 23 also found a higher Paco 2 in sleep apnea patients than in control subjects, which was not the case in our study; this discrepancy is likely related to a higher proportion of overlap syndromes in their population, because their patients with OSA had lower FEV 1 and FVC than patients without OSA, which we did not find. Some studies have even suggested that lower lung volumes and increased airway resistance contribute to the severity of OSA. 26 However, AHI did not correlate to indices of bronchial obstruction (ie, FEV 1 and FEV 1 /FVC) in our patients. Other studies also suggested that the development of hypercapnia in OSA patients requires the presence of an associated bronchial obstruction. 24,27 However, this was not found in a study of 111 patients in which the only predictive factors of hypercapnia were Pao 2 and female sex, 25 although the sex-related difference in Paco 2 did not reach significance in a subsequent analysis of this population. 28 In our study, there was no trend toward a higher Paco 2 in women than in men, despite a higher BMI. As in other studies of flow-volume curves and UAO indices, we found that the saw-tooth pattern 12 and the FEF 50 /FIF 50 ratio 29 are not useful for OSA case finding. Conversely, we found that the FEV 1 / FEV 0.5 ratio, which has been shown to detect UAO when 1.5, was a predictor of OSA in the logistic regression analysis when 1.3. 15 However, there was a great overlap between patients with OSA and patients without OSA (Fig 2). Various oximetric indices have been studied for case finding of OSA, with sensitivities ranging from 40 to 100% and specificities ranging from 39 to 100%. 6 In patients with OSA, we found that minsao 2 and msao 2 were lower, and CT 80 higher, than in patients without OSA. Indeed, AHI was negatively correlated with minsao 2 and msao 2, and positively correlated with CT 80. Finally, msao 2 was a predictor of OSA according to logistic regression analysis. After determination of optimal thresholds by ROC curves, the oximetric criteria were the variables that had the best diagnostic values, as expressed by the area under the ROC curve 30 (Table 3); however, this diagnostic value was not good enough to be useful as a screening technique (Fig 2). This limitation was also pointed out by Gyulay and coworkers, 31 who analyzed home nocturnal oximetry. In fact, a combination of independent clinical, functional, and oximetric features allowed prediction of the presence or absence of OSA with an accuracy of 100% in only a small number of patients (8%), and we could not find any other clinically useful combination of variables. Despite a trend toward a higher CT 80 for men with OSA, logistic regression did not show any interaction between sex and oximetric data. Logistic regression analysis provided a model that would have allowed to diagnose or exclude OSA confidently in 72.5% of our population. However, this model is rather complex because it includes 19 variables, which makes it unlikely to be used in clinical practice. A more simple equation, on the other hand, would not be accurate enough to be useful. In any case, such a model must be validated by prospective testing in other series of patients before being used in practice. 9 Finally, the choice of PSG as a reference test for measurement of respiratory events, and of AHI for expression of results and discrimination between OSA and non-osa subjects, may be controversial, 1542 Clinical Investigations

Figure 3. Calculated probability of having OSA (ie, AHI 15/h) as a function of measured AHI. The probability was calculated as follows: p e y /(1 e y ), where y c (constant) x 1 Variable1 x 2 Variable 2..., with parameter estimates (x 1,x 2, etc) being calculated by logistic regression analysis. Left, Pisthe calculated probability of having OSA when all variables were introduced in the regression equation. Ninety percent of patients with P 0.75 had OSA, while 94% of patients with P 0.35 did not have OSA. Right, P is the calculated probability of having OSA when variables introduced in the equation were restricted to those independently predicting OSA according to the ascendant Wald method. Eighty percent of patients with P 0.25 did not have OSA. because some studies found a poor correlation between AHI and some important clinical features of OSA such as daytime sleepiness. 32 However, PSG remains the gold standard for the diagnosis of OSA despite extensive research on new diagnostic methods, and it seemed important to use the same reference test as in most studies in this field. 9,16,17 For the same reason, an AHI threshold of 15 events/h was chosen for the diagnosis of OSA. 33 We confirmed, however, that changing this cut-off value to 10 events/h did not modify our results. We conclude that individual clinical, functional, and oximetric features do not adequately predict OSA in an overweight population (one third of which was female), and do not provide significant sex-related discrepancies. A predictive model developed by logistic regression analysis may be useful in 72.5% of patients, but this model is complex and its validity needs to be further tested in other series of patients. ACKNOWLEDGMENT: The authors wish to thank Philippe- François Bernard and Alain Beauchet for their help. References 1 Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230 1235 2 Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996; 19:104 115 3 Young T. 1. Epidemiology of sleep apnea: analytic epidemiology studies of sleep disordered breathing what explains the gender difference in sleep disordered breathing? Sleep 1993; 16:S1 S2 4 Guilleminault C, Quera-Salva MA, Partinen M, et al. Women and the obstructive sleep apnea syndrome. Chest 1988; 93:104 109 5 Rauscher H, Popp W, Zwick H. Model for investigating snorers with suspected sleep apnea. Thorax 1993; 48:275 279 6 Ferber R, Millman R, Coppola M, et al. ASDA standards of practice: portable recording in the assessment of obstructive sleep apnea. Sleep 1994; 17:378 392 7 Flemons WW, Whitelaw WA, Brant R, et al. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994; 150:1279 1285 8 Viner S, Szalai JP, Hoffstein V. Are history and physical examination a good screening test for sleep apnea? Ann Intern Med 1991; 115:356 359 9 Deegan PC, McNicholas WT. Predictive value of clinical features for the obstructive sleep apnea syndrome. Eur Respir J 1996; 9:117 124 10 Williams AJ, Yu G, Santiago S, et al. Screening for sleep apnea using pulse oximetry and a clinical score. Chest 1991; 100:631 635 11 Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19(suppl 5):1 95 12 Katz I, Zamel N, Slutsky AS, et al. An evaluation of flowvolume curves as a screening test for obstructive sleep apnea. Chest 1990; 98:337 340 13 Vincken W, Elleker G, Cosio MG. Detection of upper airway muscle involvement in neuro-muscular disorders using the flow-volume loop. Chest 1986; 90:52 57 CHEST / 116 / 6/ DECEMBER, 1999 1543

14 Mellisant AC, Van Noord JA, Van de Woestijne KP, et al. Comparison of dynamic lung function indices during forced and quiet breathing in upper airway obstruction, asthma, and emphysema. Chest 1990; 98:77 83 15 Rotman HH, Liss HP, Weg JG. Diagnosis of upper airway obstruction by pulmonary function testing. Chest 1975; 68: 796 799 16 Crocker BD, Olson LG, Saunders NA, et al. Estimation of the probability of disturbed breathing during sleep before a sleep study. Am Rev Respir Dis 1990; 142:14 18 17 Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992; 339:347 350 18 American Thoracic Society. Definition, epidemiology, pathophysiology, diagnosis and staging of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:578 583 19 Hoffstein V, Szalai JP. Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep 1993; 16:118 122 20 Williamson D. Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med 1993; 119: 646 649 21 Redline S, Kump K, Tishler PV, et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994; 149:722 726 22 Davies RJO, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnea syndrome. Thorax 1992; 47:101 105 23 Gold AR, Schwartz AR, Wise RA, et al. Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest 1993; 103:1325 1329 24 Bradley TD, Rutherford R, Lue F, et al. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 1986; 134:920 924 25 Leech JA, Önal E, Baer P, et al. Determinants of hypercapnia in occlusive sleep apnea syndrome. Chest 1987; 92:807 813 26 Önal E, Leech JA, Lopata M. Relationship between pulmonary function and sleep-induced respiratory abnormalities. Chest 1985; 87:437 441 27 Javaheri S, Colangelo G, Lacey W, et al. Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome. Sleep 1994; 17:416 423 28 Leech JA, Önal E, Dulberg C, et al. A comparison of men and women with occlusive sleep apnea syndrome. Chest 1988; 94:983 988 29 Krieger J, Weitzenblum E, Vandevenne A, et al. Flow-curve abnormalities and obstructive sleep apnea syndrome. Chest 1985; 87:163 167 30 Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983; 148:839 843 31 Gyulay S, Olson LG, Hensley MJ, et al. A comparison of clinical assessment and home oximetry in the diagnosis of obstructive sleep apnea. Am Rev Respir Dis 1993; 147:50 53 32 Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154:279 289 33 McNicholas WT, Deegan PC. Clinical prediction rules in obstructive sleep apnea syndrome. Eur Respir J 1997; 10: 1194 1195 1544 Clinical Investigations